Leber Hereditary Optic Neuropathy (LHON): Genetics and Ophthalmology Case Report

Main Article Content

Jhan Sebastian Saavedra Torres
Ingrid Nohemy Quistanchala Sánchez
Carlos Andrés Clavijo
Nataly Vanesa Pérez Martínez

Abstract

It is important to recognize that this clinical case demonstrates that carriers can remain asymptomatic, there may be changes recognizable in the ophthalmological examination. The clinical onset of Leber hereditary optic neuropathy (LHON) usually occurs in young adulthood (ages 18-30) and is divided into subacute (<6 months from onset) and dynamic (6-12 months) stages. It is caused by a mitochondrial mutation that is transmitted from mothers to children. It is the most common inherited mitochondrial disorder, but it is considered a rare disease. It usually causes severe vision loss in both eyes. The classic presentation of LHON is that of a young adult male who develops a severe, painless, acute or subacute unilateral vision loss, followed by a similar vision loss in the fellow eye two to three months later (although rarely the delay can be much longer). In most cases, it starts affecting only one eye and, within a few weeks or months, affects the second eye. It can all be seen with the loss of the pupil's ability to react to light. Complete blindness is rare among patients suffering from this disease.

Article Details

How to Cite
Jhan Sebastian Saavedra Torres, Ingrid Nohemy Quistanchala Sánchez, Carlos Andrés Clavijo, & Nataly Vanesa Pérez Martínez. (2024). Leber Hereditary Optic Neuropathy (LHON): Genetics and Ophthalmology Case Report. International Journal of Medical Science and Clinical Research Studies, 4(05), 880–883. https://doi.org/10.47191/ijmscrs/v4-i05-18
Section
Articles

References

I. Yu-Wai-Man P, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002 Mar;39(3):162-9. doi: 10.1136/jmg.39.3.162. PMID: 11897814; PMCID: PMC1735056.

II. Koilkonda RD, Guy J. Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside. J Ophthalmol. 2011;2011:179412. doi: 10.1155/2011/179412. Epub 2010 Dec 26. PMID: 21253496; PMCID: PMC3021870.

III. Hage R, Vignal-Clermont C. Leber Hereditary Optic Neuropathy: Review of Treatment and Management. Front Neurol. 2021 May 26;12:651639. doi: 10.3389/fneur.2021.651639. PMID: 34122299; PMCID: PMC8187781.

IV. Mao YJ, Qu J, Guan MX. [The influence of mitochondrial haplogroup on Leber's hereditary optic neuropathy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Feb;25(1):45-9. Chinese. PMID: 18247303.

V. Peverelli L, Catania A, Marchet S, Ciasca P, Cammarata G, Melzi L, Bellino A, Fancellu R, Lamantea E, Capristo M, Caporali L, La Morgia C, Carelli V, Ghezzi D, Bianchi Marzoli S, Lamperti C. Leber's Hereditary Optic Neuropathy: A Report on Novel mtDNA Pathogenic Variants. Front Neurol. 2021 Jun 9;12:657317. doi: 10.3389/fneur.2021.657317. PMID: 34177762; PMCID: PMC8220086.

VI. Caporali L, Iommarini L, La Morgia C, Olivieri A, Achilli A, Maresca A, et al.. Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber's hereditary optic neuropathy. PLoS Genet. (2018) 14:e1007210.

1371/journal.pgen.1007210

VII. Achilli A, Iommarini L, Olivieri A, Pala M, Hooshiar Kashani B, Reynier P, et al.. Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy. PLoS One. (2012) 7:e42242. 10.1371/journal.pone.0042242

VIII. Caporali L, Maresca A, Capristo M, Del Dotto V, Tagliavini F, Valentino ML, et al.. Incomplete penetrance in mitochondrial optic neuropathies. Mitochondrion. (2017) 36:130–7. 10.1016/j.mito.2017.07.004

IX. Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, et al.. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. (2009) 50:3112–5. 10.1167/iovs.08-3166

X. Barboni P, Carbonelli M, Savini G, Ramos CV, Carta A, Berezovsky A, et al.. Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. (2010) 117:623–7. 10.1016/j.ophtha.2009.07.026

XI. Huoponen K, Puomila A, Savontaus ML, Mustonen E, Kronqvist E, Nikoskelainen E. Genetic counseling in Leber hereditary optic neuropathy (LHON). Acta Ophthalmol Scand. 2002 Feb;80(1):38-43. doi: 10.1034/j.1600-0420.2002.800108.x. PMID: 11906302.

Most read articles by the same author(s)